IP Library Granted Patent US 6,884,905
Granted Patent B2
US 6,884,905 · App. 10/374,508 · Granted Apr 26, 2005

Degradable carbamate-containing bis(acryloyl) crosslinkers, and degradable crosslinked hydrogels comprising them

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,884,905
App. No.
10/374,508
Granted
Apr 26, 2005
Kind
B2
Abstract

One aspect of the present invention relates to base-labile, carbamate-containing crosslinkers. A second aspect of the present invention relates to degradable crosslinked polymers and hydrogels comprising a base-labile, carbamate-containing crosslinker. The present invention also relates to methods of preparing base-labile, carbamate-containing crosslinkers. Another aspect of the present invention relates to methods of preparing cross-linked polymers and hydrogels comprising a base-labile, carbamate-containing crosslinker.

Claims (67)

1. A compound represented by 1:

wherein

X represents independently for each occurrence O or S;

L represents independently for each occurrence —O—NH—Q;

Q represents independently for each occurrence acryloyl, 2-alkylacryloyl, 3-alkylacryloyl, 2,3-dialkylacryloyl, 3,3-dialkylacryloyl, 2,3,3-trialkylacryloyl, acryloylO(CR 2 ) n C(O)—, 2-alkylacryloylO(CR 2 ) n C(O)—, 3-alkylacryloylO(CR 2 ) n C(O)—, 2,3-dialkylacryloylO(CR 2 ) n C(O)—, 3,3-dialkylacryloylO(CR 2 ) n C(O)—, 2,3,3-trialkylacryloylO(CR 2 ) n C(O)—, (diene)C(O)—, (vinyl)(CR 2 ) n C(O)—, or (vinyl)ArC(O)—;

R represents independently for each occurrence H or alkyl;

Z represents —NH(CR 2 ) n NH—, or —NH(CR 2 ) n J(CR 2 ) m NH—;

Ar represents independently for each occurrence aryl or heteroaryl;

J represents independently for each occurrence O, S, NR, cycloalkyl, heterocyclyl, (CH 2 CH 2 O) n , or (CH 2 CH 2 N(R)) n ;

n represents independently for each occurrence an integer in the range 1-10; and

m represents independently for each occurrence an integer in the range 0-10.

2. The compound of claim 1 , wherein X represents O.

3. The compound of claim 1 , wherein Q represents acryloyl, or 2-methacryloyl.

4. The compound of claim 1 , wherein R represents H.

5. The compound of claim 1 , wherein Z represents —NH(CR 2 ) n NH—.

6. The compound of claim 1 , wherein X represents O; and L represents —O—NH—Q.

7. The compound of claim 1 , wherein X represents O; L represents —O—NH—Q; and Q represents acryloyl, or 2-methacryloyl.

8. The compound of claim 1 , wherein X represents O; L represents —O—NH—Q; Q represents acryloyl, or 2-methacryloyl; and R represents H.

9. The compound of claim 1 , wherein X represents O; L represents —O—NH—Q; Q represents acryloyl, or 2-methacryloyl; R represents H; and Z represents —NH(CR 2 ) n NH—.

10. A compound represented by 2:

wherein

X represents independently for each occurrence O or S;

M represents independently for each occurrence —O—NH—Q;

Q represents independently for each occurrence acryloyl, 2-alkylacryloyl, 3-alkylacryloyl, 2,3-dialkylacryloyl, 3,3-dialkylacryloyl, 2,3,3-trialkylacryloyl, acryloylO(CR 2 ) n C(O)—, 2-alkylacryloylO(CR 2 ) n C(O)—, 3-alkylacryloylO(CR 2 ) n C(O)—, 2,3-dialkylacryloylO(CR 2 ) n C(O)—, 3,3-dialkylacryloylO(CR 2 ) n C(O)—, 2,3,3-trialkylacryloylO(CR 2 ) n C(O)—, (diene)C(O)—, (vinyl)(CR 2 ) n C(O)—, or (vinyl)ArC(O)—;

R represents independently for each occurrence H or alkyl;

Z represents —NH(CR 2 ) n NH—, or —NH(CR 2 ) n J(CR 2 ) m NH—;

Ar represents independently for each occurrence aryl or heteroaryl;

J represents independently for each occurrence O, S, NR, cycloalkyl, heterocyclyl, (CH 2 CH 2 O) n , or (CH 2 CH 2 N(R)) n ;

G represents (CR (4−t) ), aryl, or heteroaryl;

n represents independently for each occurrence an integer in the range 1-10;

m represents independently for each occurrence an integer in the range 0-10; and

t represents 3 or 4.

11. The compound of claim 10 , wherein X represents O.

12. The compound of claim 10 , wherein Q represents acryloyl, or 2-methacryloyl.

13. The compound of claim 10 , wherein R represents H.

14. The compound of claim 10 , wherein X represents O; and M represents —O—NH—Q.

15. The compound of claim 10 , wherein X represents O; M represents —O—NH—Q; and Q represents acryloyl, or 2-methacryloyl.

16. The compound of claim 10 , wherein X represents O; M represents —O—NH—Q; Q represents acryloyl, or 2-methacryloyl; and R represents H.

17. A method of preparing a compound represented by 1:

wherein

X represents independently for each occurrence O or S;

L represents independently for each occurrence —O—NH—Q;

Q represents independently for each occurrence acryloyl, 2-alkylacryloyl, 3-alkylacryloyl, 2,3-dialkylacryloyl, 3,3-dialkylacryloyl, 2,3,3-trialkylacryloyl, acryloylO(CR 2 ) n C(O)—, 2-alkylacryloylO(CR 2 ) n C(O)—, 3-alkylacryloylO(CR 2 ) n C(O)—, 2,3-dialkylacryloylO(CR 2 ) N C(O)—, 3,3-dialkylacryloylO(CR 2 ) n C(O)—, 2,3,3-trialkylacryloylO(CR 2 ) n C(O)—, (diene)C(O)—, (vinyl)(CR 2 ) n C(O)—, or (vinyl)ArC(O)—;

R represents independently for each occurrence H or alkyl;

Z represents —NH(CR 2 ) n NH—, or —NH(CR 2 ) n J(CR 2 ) m NH—;

Ar represents independently for each occurrence aryl or heteroaryl;

J represents independently for each occurrence O, S, NR, cycloalkyl, heterocyclyl, (CH 2 CH 2 O) n , or (CH 2 CH 2 N(R)) n ;

n represents independently for each occurrence an integer in the range 1-10; and

m represents independently for each occurrence an integer in the range 0-10.

(a) reacting a hydroxylamine with an acrylate, thereby forming an acrylic hydroxamic acid; and

(b) reacting said acrylic hydroxamic acid with a diisocyanate.

18. A method of preparing a compound represented by 2:

wherein

X represents independently for each occurrence O or S;

M represents independently for each occurrence —O—NH—Q;

Q represents independently for each occurrence acryloyl, 2-alkylacryloyl, 3-alkylacryloyl, 2,3-dialkylacryloyl, 3,3-dialkylacryloyl, 2,3,3-trialkylacryloyl, acryloylO(CR 2 ) n C(O)—, 2-alkylacryloylO(CR 2 ) n C(O)—, 3-alkylacryloylO(CR 2 ) n C(O)—, 2,3-dialkylacryloylO(CR 2 ) n C(O)—, 3,3-dialkylacryloylO(CR 2 ) n C(O)—, 2,3,3-trialkylacryloylO(CR 2 ) n C(O)—, (diene)C(O)—, (vinyl)(CR 2 ) n C(O)—, or (vinyl)ArC(O)—;

R represents independently for each occurrence H or alkyl;

Z represents —NH(CR 2 ) n NH—, or —NH(CR 2 ) n J(CR 2 ) m NH—;

Ar represents independently for each occurrence aryl or heteroaryl;

J represents independently for each occurrence O, S, NR, cycloalkyl, heterocyclyl, (CH 2 CH 2 O) n , or (CH 2 CH 2 N(R)) n ;

G represents (CR (4−t) ), aryl, or heteroaryl;

n represents independently for each occurrence an integer in the range 1-10;

m represents independently for each occurrence an integer in the range 0-10; and

t represents 3 or 4;

comprising:

(a) reacting a hydroxylamine with an acrylate, thereby forming a hydroxamic acid; and

(b) reacting said hydroxamic acid with a triisocyanate or tetraisocyanate.

Assignments (3)
SECURITY INTEREST Recorded Sep 16, 2016
From: BIOSPHERE MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 039766/0333 →
PATENT SECURITY AGREEMENT Recorded Jan 25, 2013
From: BIOSPHERE MEDICAL, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 029698/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2003
From: ZHANG, HONGMIN; SCHWARZ, ALEXANDER
To: BIOSPHERE MEDICAL
Reel/Frame 014229/0168 →